negatives of semaglutide Safety & Side Effects Considering a Weight Loss Drug?

The TB-500 component thymosin -4 is prohibited at all times under section S2 of the WADA Prohibited List (peptide hormones, growth factors, related substances and mimetics), which expressly names thymosin--4 and its derivatives

The 48-hour protocol provides more consistent absorption and clearer differentiation between normal HPA axis function and true Cushings syndrome

Results found that patients treated with semaglutide had an average body mass index (BMI) decrease from 43.1 to 41.5 (95% CI, 2.041 to 10.4

F.Pi-SunyerF

2015;12(3):e1001779

These changes typically normalize as your body adapts, though they may recur with each dose increase